Table 2.
The available cases of non-parathyroid hormone-dependent hypercalcemia in acromegaly
| Study ID | Age Sex |
Course years |
Time and reference range |
GH ng/ml |
IGF-1 ng/ml |
PRL ng/ml |
Sca mg/dL |
Sp mg/dL |
Uca mg/24h |
PTH Pg/mL |
25D ng/ml |
1,25D pg/ml |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2010Shah1 | 50/F | 2+ | on addmission | 14.5 | 911 | 33 | 10.3 | - | 388 | 20 | 34 | 119 |
| 3-month Post | 1.4 | 197 | 11.3 | 10.0 | - | 152 | 41 | 48 | 50 | |||
| Normal range | 0.03-10 | 49-292 | 1-24 | 8.6-10.2 | - | 100-300 | 10-65 | 30-80 | 15-75 | |||
| 2010Shah2 | 51/F | 2+ | on addmission | 75.8 | 425 | 67.1 | 10.7 | - | - | 19 | 44 | 66 |
| 1-week Post | 18.5 | 246 | 36 | 8.5 | - | - | - | - | - | |||
| 2-month Post | 12.8 | 440 | 10 | 10.7 | - | 199 | 23 | 30.6 | 81.3 | |||
| Normal range | 0.03-10 | 49-292 | 1-24 | 8.6-10.2 | - | 100-300 | 10-65 | 30-80 | 15-75 | |||
| 2014Pooja | 67/F | 10+ | on addmission | 92.0 | 1498 | 223.2 | 10.7 | 4.1 | 356.4 | 13 | 30.2 | 72.6 |
| 3-month Post | 1.07 | 304 | 4.2 | 9.9 | 4.3 | 192.6 | 25 | 45.3 | 38.6 | |||
| Normal range | 0-3.61 | 59-225 | 2-17.4 | 8.5-10.5 | 2.5-4.9 | 100-300 | 10-60 | 31-80 | 15-60 | |||
| Present report | 37/M | 6+ | on addmission | 15.5 | >600 | 585 | 10.7 | 5.48 | 231.3 | 24 | 15.9 | - |
| 3-month Post | 1.26 | 154.85 | 2.92 | 9.4 | 4.15 | 48.6 | 52.5 | 22.8 | - | |||
| Normal range | 0.03-2.5 | 86-196 | 4.6-21 | 8.5-10.1 | 2.6-4.6 | 100-300 | 14-63 | 19-58 | - |
GH indicates growth hormone, IGF-1 insulin-like growth factor-1, PRL prolactin, Sca serum calcium, Sp serum phosphorus, Uca urinary calcium, PTH parathyroid hormone, 25D 25 hydroxyvitamin D, 1,25D 1,25-dihydroxyvitamin D, Post post-treatment, F female, M male, -, no data